Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Compare and contrast
14 December, 2018
Choosing comparators is often an onerous process that involves navigating...
> read more

Strong ties 14 December, 2018 Social media is a powerful tool for patient recruitment, providing a valuable addition to more traditional methods. It can be harnessed to build strong relationships between...

Keep it cool 14 December, 2018 In a world where supply chains can span multiple national borders, and the regulatory environment is becoming more demanding, good collaboration between partners is essential. Kim...

Cool runnings 14 December, 2018 With the stakes being so high for cold chain, finding new ways to maximise efficiencies and prevent revenue losses is key. Digitisation is a cost-effective option with huge potential,...

New direction 14 December, 2018 The growth of direct-to-patient (DtP) clinical trial strategies is expected to continue for the foreseeable future. Adopting a DtP approach has the potential to improve...

A sea change 14 December, 2018 The last 25 years have seen a dramatic evolution in clinical trials and processes. The delivery of investigational medicinal products to clinical sites and patients is...

Ride the tidal wave of data 14 December, 2018 The variety and quantity of data available for clinical trials is greater than ever before. While this promises huge benefits in terms of monitoring subjects and measuring results,...

Perfect harmony 14 December, 2018 The way clinical trials are conducted in the EU will experience a significant shift when Regulation (EU) no. 536/2014 (termed Clinical Trial Regulation) is implemented in 2019 and...

Blockchain: behind the buzzwords 14 December, 2018 As the hype around blockchain has exploded, its actual applications have become harder to discern. However, specific aspects of the technology have the potential to address the...

Straight to the source 14 December, 2018 Choosing between full-service and functional-service outsourcing models isn’t a new debate in the pharmaceutical and biotech industries, but balancing the need for high-quality...

Through the keyhole 14 December, 2018 A number of strategies are being developed to help the UK compete in the global research market post-Brexit, including the creation of ‘high-throughput centres’ to accelerate phase-II...

Safely delivering the goods: a successful supply chain 25 September, 2018 It is often the final stage of a drug’s journey that can be the most hazardous. Ensuring the cold chain is not broken means understanding a number of variables. Erik Agterhuis,...

Room for improvement: cold-chain pharmaceuticals 25 September, 2018 Huge investment and attention have been spent on improving and standardising the safe shipment of cold chain pharmaceuticals, but to what extent is there a danger of all this...

Medicine for the planet: sustainable packaging 25 September, 2018 The primary job of packaging is to ensure the safety of pharmaceutical products, but the wrong choice of material can be detrimental to a company’s sustainability goals – especially if...

Calculating risk 25 September, 2018 Last year, the International Society for Pharmaceutical Engineering released the second edition of ‘Baseline Guide: Risk-Based Manufacture of Pharmaceutical Products’, to help manage...

Packing heat: temperature control during storage and distribution 25 September, 2018 Uncontrolled temperature fluctuation during distribution and storage can be a significant source of revenue loss, and pharmaceutical companies are increasingly looking for new ways...

Keep on track and trace: benefit of traceability in the supply chain 25 September, 2018 With regulatory requirements evolving fast, much of the discussion around track and trace revolves around meeting compliance deadlines. However, there is a strong business case for...

Getting ready for serialisation: 'track and trace' solutions 25 September, 2018 EU and US deadlines for serialisation, and track and trace are fast approaching, but many pharmaceutical companies remain dangerously unprepared. With time running out, Patrick...

Combinational pride: the complexity of mixing drugs, devices and biologics 25 September, 2018 As combination products become more prevalent, they pose a number of regulatory challenges. Essentially, it isn’t always clear whether a product should be regulated as a drug, biologic...

A winning combination: digital solutions for medical treatments 25 September, 2018 The market for combination products is rapidly expanding, in part due to advances in digital health technology. World Pharmaceutical Frontiers considers the directions these...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.
cachename:Featurescachekey:rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_1595691727